Thr628

Site Information
SGMTVRstGsAtsLA SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 2526220
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 )
Disease tissue studied:	lung cancer ( 1 , 2 ) , non-small cell lung cancer ( 1 , 3 ) , non-small cell lung adenocarcinoma ( 1 , 2 ) , non-small cell large cell lung carcinoma ( 1 )
Relevant cell line - cell type - tissue:	293 (epithelial) ( 4 ) , HeLa (cervical) ( 5 ) , lung ( 1 , 2 ) , NCI-H1299 (pulmonary) ( 1 ) , NCI-H1734 (pulmonary) ( 1 ) , NCI-H1944 (pulmonary) ( 1 ) , NCI-H3255 (pulmonary) ( 3 ) , NCI-H358 (pulmonary) ( 1 ) , NCI-H460 (pulmonary) ( 1 )

References
1	Rikova K, Hall B (2013) CST Curation Set: 20737, 21164, 30161, 30162, 30163; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P Curated Info
2	Schweppe DK, Rigas JR, Gerber SA (2013) Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 91, 286-96 23911959 Curated Info
3	Rikova K (2012) CST Curation Set: 16146; Year: 2012; Biosample/Treatment: cell line, H3255/iressa; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pSQ, p[ST]QG Antibodies Used to Purify Peptides prior to LCMS: Phospho-ATM/ATR Substrate (SQ) (D23H2/D69H5) Rabbit mAb Cat#: 9607 Phospho-(Ser/Thr) ATM/ATR Substrate (S/T*QG) (P-S/T2-100) Rabbit mAb Cat#: 6966 Curated Info
4	Gauci S, et al. (2009) Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem 81, 4493-501 19413330 Curated Info
5	Dephoure N, et al. (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105, 10762-7 18669648 Curated Info